Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06059716 · ClinicalTrials.gov registry record · NA
Gluten Technology and Education for Celiac Health
A NA study of Celiac Disease, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 4
- Study locations
NCT06059716: Recruiting NA study of Celiac Disease, sponsored by Columbia University.
NCT06059716 is a NA study of Celiac Disease that is actively recruiting participants, run by Columbia University. The registered enrollment target is 200 participants, below the 1,972-participant average among 24 other Celiac Disease trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06059716, a NA study of Celiac Disease, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention will improve mucosal recovery, promote a shift in current practice of celiac disease management toward long-term monitoring, and represent a significant step toward reducing the severe physical and psychological consequences of celiac disease.
Primary Outcome
This will be measured with a measure in villus height to crypt depth ratio on small intestinal biopsy.
Conditions Studied
Interventions
- BEHAVIORAL Gluten detection technology
- BEHAVIORAL Continuous telemedicine monitoring
Study Locations (4)
Illinois
- University of Chicago Medical Center - Chicago
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
New York
- Columbia University Irving Medical Center - New York
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-10-08 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What NCT06059716 shows while recruiting
NCT06059716 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,972-participant average among 24 other Celiac Disease trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Celiac Disease appearing as the primary indexed condition, and to 2 interventions - of which Gluten detection technology is the first listed.
NCT06059716 reports a single indexed study location in Illinois, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT06059716 about?
NCT06059716 is a clinical study titled "Gluten Technology and Education for Celiac Health". The investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention will improve mucosal re...
What is the current status of trial NCT06059716?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-10-08. Estimated completion is 2028-08-31.
What conditions does trial NCT06059716 study?
This clinical trial studies the following conditions: Celiac Disease.
What interventions are being tested in trial NCT06059716?
The interventions under investigation include: Gluten detection technology (BEHAVIORAL), Continuous telemedicine monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT06059716?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06059716 being conducted?
This trial has 4 study locations across Illinois, Massachusetts, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Celiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06059716's enrollment target sits among peer trials
200 10th of 24 higher than 14 of 24 other Celiac Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Celiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tissue Destruction and Healing in Celiac Disease
RECRUITING · NA
-
Immune Responses to Gluten
RECRUITING · NA
-
T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge
COMPLETED · NA
-
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
COMPLETED · NA
-
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
COMPLETED · NA
-
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI